On September 17, 2024, Maison Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market LLC under the trading symbol MSS, disclosed in a Form 8-K filing with the SEC that it had received a Nasdaq Staff Deficiency Letter. The letter informed the company that its common stock bid price had been below the $1.00 minimum requirement for continued listing on The Nasdaq Capital Market for the past thirty consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Maison Solutions has been granted an initial 180-day period, until March 17, 2025, to regain compliance with the Minimum Bid Price Requirement. The company's stock will remain listed and tradable on Nasdaq during this period, and Maison Solutions is actively exploring options to address the...Show More

On September 17, 2024, Maison Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market LLC under the trading symbol MSS, disclosed in a Form 8-K filing with the SEC that it had received a Nasdaq Staff Deficiency Letter. The letter informed the company that its common stock bid price had been below the $1.00 minimum requirement for continued listing on The Nasdaq Capital Market for the past thirty consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Maison Solutions has been granted an initial 180-day period, until March 17, 2025, to regain compliance with the Minimum Bid Price Requirement. The company's stock will remain listed and tradable on Nasdaq during this period, and Maison Solutions is actively exploring options to address the deficiency and regain compliance, which may include a reverse stock split if necessary. If compliance is not achieved within the initial period, the company may be eligible for an additional 180-day period, provided it meets certain conditions. However, there is no guarantee that Maison Solutions will qualify for this extension or avoid delisting.